Literature DB >> 14178030

OBSERVATIONS ON THE PROTECTIVE EFFECT OF BCG VACCINATION IN A SOUTH INDIAN RURAL POPULATION.

J FRIMODT-MOLLER, J THOMAS, R PARTHASARATHY.   

Abstract

Doubts have been raised on theoretical grounds concerning the effect of BCG in tropical countries, where in most places a large proportion of the population have a naturally acquired tuberculin allergy of low strength and unknown (but almost certainly non-specific) origin. Furthermore, vaccinations in the tropics may be less efficient if the BCG vaccine used has deteriorated from exposure to heat or light. The BCG trial reported here is relevant to these two problems.A series of epidemiological studies in South India, begun in 1950 and still in progress, included a BCG trial in which half of the tuberculin-negative persons, randomly selected, were vaccinated. In a first report in 1960, preliminary data indicated that the vaccination had conferred no protection against tuberculosis; however, the total number of cases of tuberculosis involved was extremely small. Since then, further follow-up has added a considerable number of cases, and a statistically significant protection from the BCG vaccination is now demonstrated. The number of cases is still too small to show the precise degree of protection.As this is the first controlled trial on BCG undertaken in an Asiatic population, the present report is of special interest.

Entities:  

Keywords:  BCG VACCINATION; EPIDEMIOLOGY; INDIA; MASS CHEST X-RAY; RURAL HEALTH; STATISTICS; TUBERCULOSIS, PULMONARY

Mesh:

Substances:

Year:  1964        PMID: 14178030      PMCID: PMC2554839     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  3 in total

1.  A community-wide tuberculosis study in a South Indian rural population, 1950-1955.

Authors:  J FRIMODT-MOLLER
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

2.  Community trials of BCG vaccination.

Authors:  C E PALMER; L W SHAW; G W COMSTOCK
Journal:  Am Rev Tuberc       Date:  1958-06

3.  A critical examination of a study of tuberculosis in Madanapalle, South India.

Authors:  K S RANGANATHAN
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

  3 in total
  10 in total

1.  Editorial: BCG vaccination.

Authors: 
Journal:  Br Med J       Date:  1975-12-13

2.  Evaluation of BCG vaccination among Puerto Rican children.

Authors:  G W Comstock; V T Livesay; S F Woolpert
Journal:  Am J Public Health       Date:  1974-03       Impact factor: 9.308

3.  Problems connected with estimating the incidence of tuberculosis infection.

Authors:  R Narain; S S Nair; P Chandrasekhar; G R Rao
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

4.  Current status of B.C.G. vaccination.

Authors:  N B Kumta; P R Sureka
Journal:  Indian J Pediatr       Date:  1980 Sep-Oct       Impact factor: 1.967

5.  Efficacy and applicability of mass B. C.G. vaccination in tuberculosis control.

Authors:  P D Hart
Journal:  Br Med J       Date:  1967-03-11

6.  A controlled study of the influence of segregation of tuberculous patients for one year on the attack rate of tuberculosis in a 5-year period in close family contacts in South India.

Authors:  S R Kamat; J J Dawson; S Devadatta; W Fox; B Janardhanam; S Radhakrishna; C V Ramakrishnan; P R Somasundaram; H Stott; S Velu
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

7.  The duration of BCG-induced tuberculin sensitivity in children, and its irrelevance for revaccination. Results of two 5-year prospective studies.

Authors:  J Guld; H Waaler; T K Sundaresan; P C Kaufmann; H G ten Dam
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

8.  Epidemiological basis of tuberculosis eradication. 10. Longitudinal studies on the risk of tuberculosis in the general population of a low-prevalence area.

Authors:  O Horwitz; E Wilbek; P A Erickson
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

9.  Nanocages engineered from Bacillus Calmette-Guerin facilitate protective Vγ2Vδ2 T cell immunity against Mycobacterium tuberculosis infection.

Authors:  Jiang Pi; Zhiyi Zhang; Enzhuo Yang; Lingming Chen; Lingchan Zeng; Yiwei Chen; Richard Wang; Dan Huang; Shuhao Fan; Wensen Lin; Hongbo Shen; Jun-Fa Xu; Gucheng Zeng; Ling Shen
Journal:  J Nanobiotechnology       Date:  2022-01-15       Impact factor: 10.435

10.  Timing of Mycobacterium tuberculosis exposure explains variation in BCG effectiveness: a systematic review and meta-analysis.

Authors:  James M Trauer; Andrew Kawai; Anna K Coussens; Manjula Datta; Bridget M Williams; Emma S McBryde; Romain Ragonnet
Journal:  Thorax       Date:  2021-04-23       Impact factor: 9.139

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.